IEQ Capital’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
Other funds holding DAWN
IEQ Capital's DAWN Position: Q2 2026 in Review
IEQ Capital sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 31,854 shares — an estimated $683K sold.
IEQ Capital first reported a position in DAWN in Q1 2025 and held it in 3 quarters. The position peaked at $683K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.
- IEQ Capital reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
- IEQ Capital sold 31,854 Day One Biopharmaceuticals shares in Q2 2026, an estimated $683K.
- IEQ Capital first reported a position in Day One Biopharmaceuticals in Q1 2025 and held it in 3 quarters.
- IEQ Capital's Day One Biopharmaceuticals position peaked at $683K in Q1 2026.
- 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.
Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.